The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
Frequently asked questions
What sector does Oncology Institute Inc (TOI) operate in?
Oncology Institute Inc belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is Oncology Institute Inc (TOI) current stock price?
As of the latest data, Oncology Institute Inc stock price is $5.13, with a previous close of $5.13.
What is Oncology Institute Inc (TOI) current market capitalization?
Oncology Institute Inc market cap is approximately 512.91 million.
What is Oncology Institute Inc (TOI) Earnings Per Share (EPS)?
The trailing EPS is -$0.35, and the forward EPS is -$0.03.
Does Oncology Institute Inc (TOI) pay dividends?
No. Oncology Institute Inc does not pay a dividend.
What is Oncology Institute Inc (TOI) beta (volatility) score?
Oncology Institute Inc has a beta of 0.422, indicating lower volatility than the overall market.
